Editorials
Efficacy and safety of COX 2 inhibitors
BMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7365.607 (Published 21 September 2002) Cite this as: BMJ 2002;325:607
Related articles
- Paper Published: 21 September 2002; BMJ 325 doi:10.1136/bmj.325.7365.619
- Paper Published: 21 September 2002; BMJ 325 doi:10.1136/bmj.325.7365.624
- Primary Care Published: 01 December 2005; BMJ 331 doi:10.1136/bmj.331.7528.1310
- Letter Published: 15 December 2005; BMJ 331 doi:10.1136/bmj.331.7530.1474-b
- Primary Care Published: 09 June 2005; BMJ 330 doi:10.1136/bmj.330.7504.1366
See more
- Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysisBMJ December 05, 2016, 355 i6188; DOI: https://doi.org/10.1136/bmj.i6188
- Proton pump inhibitors and community acquired pneumoniaBMJ November 17, 2016, 355 i6041; DOI: https://doi.org/10.1136/bmj.i6041
- NSAIDs and the failing heartBMJ September 28, 2016, 354 i5163; DOI: https://doi.org/10.1136/bmj.i5163
- Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control studyBMJ September 28, 2016, 354 i4857; DOI: https://doi.org/10.1136/bmj.i4857
- Data feedback and behavioural change intervention to improve primary care prescribing safety (EFIPPS): multicentre, three arm, cluster randomised controlled trialBMJ August 18, 2016, 354 i4079; DOI: https://doi.org/10.1136/bmj.i4079
Cited by...
- COX-2 inhibitors and the heart: are all coxibs the same?
- Risk of gastrointestinal effects with COX-2 inhibitors and NSAIDs: COX-2 inhibitors were thought of as a safe option
- Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis
- Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis
- Celecoxib But Not Rofecoxib Inhibits the Growth of Transformed Cells in Vitro
- Systematic review of celecoxib for osteoarthritis and rheumatoid arthritis
- Celecoxib: Equally Efficacious, Less GI Toxic Than Other NSAIDs
- Celecoxib: Equally Efficacious, Less GI Toxic Than Other NSAIDs